One Lot of Coumadin Recalled Over Potency Fears

Lot of Coumadin recalled
Lot of Coumadin recalled

Bristol-Myers Squibb

recalled one lot of its blood thinner medicine Coumadin after tests showed the tablets could be more potent than the dosage, said the U.S. Food and Drug Administration (FDA).

-- also known as warfarin sodium -- is prescribed to treat and prevent blood clots, and to lower the risk of heart attacks and strokes. However, too much of the active ingredient in the medication means there would be an increased risk of bleeding, the FDA said.

Consumers should talk to their doctors immediately if they experience any problems, including pain, swelling, headache and dizziness, unusual bruising, nosebleeds and bleeding from cuts that take a long time to stop.

Originally published